Thema: US6700024010
NVAX, US6700024010
ethereum-6851392_1920.jpg - Foto: THN
Novavax stock: Sanofi milestone lifts 2026 revenue outlook
Novavax stock drew attention after a Sanofi milestone was triggered by a combination-vaccine trial. The company raised its 2026 revenue outlook.
ad-hoc-news.de, 06.11.26 22:24 Uhr
NVAX, US6700024010
Novavax stock: Sanofi trial triggers $125 million milestone ...
Novavax stock faces a new partnership catalyst after Sanofi dosed the fifth patient in a Phase 3 trial. Results are due November 5.
ad-hoc-news.de, 30.10.26 18:39 Uhr
NVAX, US6700024010
Cantor Fitzgerald sets USD 18 target for Novavax stock
Novavax posted USD 57.00 million revenue in second quarter 2026, down from USD 239.00 million. Novavax stock costs EUR 8.96 on October 27, 2026.
ad-hoc-news.de, 27.10.26 21:30 Uhr
NVAX, US6700024010
Bank of America keeps USD 8.00 target for Novavax stock
Bank of America keeps its USD 8.00 target on October 23, 2026. Novavax stock costs EUR 8.70 on October 24, 2026 at 1:04 p.m. CEST.
ad-hoc-news.de, 24.10.26 19:54 Uhr
NVAX, US6700024010
Citi lifts its target for Novavax stock to USD 8.00
Novavax set a USD 255.00 million 2026 midpoint on August 6. Novavax stock is EUR 10.15 on October 20, 2026, up 1.60 percent versus Tradegate.
ad-hoc-news.de, 20.10.26 20:06 Uhr
NVAX, US6700024010
Novavax stock fell 12.17 percent on October 16 2026 15.91 ...
Revenue fell 76.20 percent to USD 56.70 million in second quarter 2026. Novavax stock was USD 11.26 on October 16, 2026, down 12.17 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 19:30 Uhr
NVAX, US6700024010
BofA raises Novavax stock target from USD 7.00 to USD 8.00 ...
Second-quarter revenue fell 76.20 percent to USD 56.70 million. Novavax stock costs EUR 11.53 on October 15, 2026.
ad-hoc-news.de, 15.10.26 20:16 Uhr
NVAX, US6700024010
Novavax outlined USD 200 million milestones. Novavax stock ...
Revenue fell 76.20 percent to USD 56.70 million in quarter two of 2026. Novavax stock costs EUR 9.71 on October 8, 2026 versus EUR 9.98.
ad-hoc-news.de, 08.10.26 17:45 Uhr
Novavax, Gains
Novavax Gains Strategic Validation Through Pfizer Adjuvants ...
Novavax US6700024010
boerse-global.de, 02.02.26 07:45 Uhr
Novavax, Secures
Novavax Secures Major Pfizer Partnership for Vaccine Technology ...
